Maternal antibodies and infant immune responses to vaccines

Kathryn M Edwards1

  • 1Sarah H. Sell and Cornelius Vanderbilt Chair in Pediatrics, Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University, 21st Avenue South, S 2323 MCN, Nashville, TN 37232, United States.

Vaccine
|August 11, 2015
PubMed

Insights

Maternal antibodies protect newborns but can hinder infant vaccine responses. This study explores how these antibodies interfere with infant immunity and vaccine effectiveness.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Infants possess immature immune systems at birth, limiting their ability to combat early-life infections.
  • Maternal antibodies, transferred via the placenta, offer crucial passive immunity to newborns.
  • Maternal antibodies are known to suppress infant immune responses to vaccinations.

Purpose of the Study:

  • To elucidate the mechanisms by which maternal antibodies inhibit infant immune responses to vaccines.
  • To discuss the implications of this inhibition on the development of long-term immunity in children.

Main Methods:

  • Review of existing literature on maternal antibody interference.
  • Analysis of immunological pathways involved in antibody-mediated suppression.
  • Discussion of experimental data and clinical observations.

Main Results:

  • Maternal antibodies can interfere with B-cell activation and antibody production in infants.
  • The presence of maternal antibodies may downregulate T-cell responses crucial for vaccine efficacy.
  • The extent of inhibition can vary depending on the specific vaccine and antibody levels.

Conclusions:

  • Understanding the mechanisms of maternal antibody interference is vital for optimizing infant vaccination strategies.
  • Strategies to overcome this inhibition may be necessary to ensure robust and lasting immunity in infants.
  • Further research is needed to develop vaccination protocols that mitigate the suppressive effects of maternal antibodies.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.9K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
12.1K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Vaccinations01:51

Vaccinations

Overview
54.0K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
37